Price Move History
- Daily moves over 5%
- 0 252 sessions, October 2, 2025 to October 2, 2026
- Largest daily move
- +4.8% close of January 8, 2026
- 1-year change
- -27.3% closing prices, October 2, 2025 to October 2, 2026
- 1-month change
- -6.1% closing prices, September 2, 2026 to October 2, 2026
Company Description
The Simplify VettaFi Private Credit Strategy ETF (NYSE Arca: PCR) is an exchange-traded fund launched by Simplify Asset Management Inc. It is described as a private credit strategy ETF that seeks to give investors exposure to private credit markets while incorporating a dedicated credit hedge. PCR is part of Simplify’s alternatives and income-focused ETF lineup and is listed on the NYSE Arca exchange.
According to Simplify, PCR’s private credit strategy seeks to track the returns of the VettaFi Private Credit Index. This index is derived from a universe of Business Development Companies (BDCs) and publicly traded Closed-End Funds (CEFs) that are primarily engaged in private credit. Potential index constituents must meet stated minimum market capitalization and liquidity requirements and are evaluated using proprietary percentile scores based on volatility and dividend yield.
A key feature highlighted for PCR is its proprietary credit hedging strategy. The fund employs a hedge that goes long stocks with high-quality metrics and short stocks that exhibit low-quality metrics. Simplify notes that this hedge has historically shown a positive correlation with credit spreads and a historical positive carry. The goal of this structure is to pair private credit exposure with a managed approach to credit risk, particularly during adverse credit events or periods of credit spread widening.
As an actively managed ETF, PCR is subject to the risk that its strategy may not achieve the intended results. The fund may use derivative instruments, including swaps and options, and may invest in other ETFs. The disclosures emphasize that derivatives can involve risks different from, or greater than, investing directly in securities, including counterparty risk, valuation risk, and the possibility that changes in derivative values may not closely track the underlying asset, rate, or index.
The risk disclosures for PCR also reference exposure to high yield debt ("junk bonds"), credit risk, and liquidity risk. High yield securities and unrated securities of similar credit quality are described as speculative with respect to an issuer’s ability to make principal and interest payments and may be more volatile than higher-rated securities. The fund is identified as non-diversified, meaning it may invest a larger portion of its assets in fewer issuers than a diversified fund, which can increase fluctuations in its share price.
Fixed income-related risks are also highlighted, including the potential impact of rising interest rates on bond prices and fund value, as well as prepayment risk and credit risk. Swaps used in the strategy are noted as being subject to tracking risk if they do not perfectly substitute for the instruments they are intended to hedge or replace.
The disclosures characterize PCR as a recently organized management investment company with no operating history at the time of its introduction. As with other ETFs, investors are encouraged to review the fund’s prospectus or summary prospectus for detailed information on investment objectives, risks, charges, and expenses, and are reminded that an investment in the fund involves risk, including possible loss of principal.
In a later announcement, Simplify Asset Management reported that the previously disclosed net asset values (NAVs) per share of the Simplify VettaFi Private Credit Strategy ETF for a specified period were restated due to incorrect swaps financing rates. The notice provided a schedule of revised and original NAVs and indicated that the adjustments were effective as of a stated date. This event underscores the role of derivatives and financing assumptions in the fund’s valuation process.
Simplify Asset Management Inc. is described in the fund’s communications as a Registered Investment Adviser founded in 2020. The firm states that it focuses on helping advisors address portfolio challenges through options-based strategies that take into account real-world investor needs, market behavior, and the non-linear characteristics of options.
Stock Performance
Simplify VettaFi Private Credit Strategy ETF (PCR) closed at $18.13 on October 2, 2026. Over the past 12 months, the price has lost 27.3%.
PCR Metrics & Rankings
Price returns through October 2, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Simplify VettaFi Private Credit Strategy ETF has 4 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 2 with negative movement. View all PCR news →
SEC Filings
Short Interest History
Short interest in Simplify VettaFi Private Credit Strategy ETF (PCR) currently stands at 1.2 thousand shares, up 97.0% from the previous reporting period, representing 1.0% of the shares outstanding. Since October 2025, short interest has increased by 1406.1%.
Days to Cover History
Days to cover for Simplify VettaFi Private Credit Strategy ETF (PCR) currently stands at 2.4 days, up 136% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has increased by 136%. Across the settlements charted above, it has ranged from 1.0 to 3.6 days.